SkylineDx BV
Biotechnology ResearchSouth Holland, Netherlands51-200 Employees
SkylineDx BV is a Rotterdam-based biotechnology research company that develops molecular diagnostics for oncology, inflammatory and infectious diseases, with a focus on gene signature-based diagnostic testing. The company employs between 51 and 200 people and is headquartered at 40 Lichtenauerlaan, Rotterdam, South Holland, Netherlands. Its mission centers on precision medicine, aiming to improve patient quality of life by providing personalized genomic insights to guide treatment decisions. A multidisciplinary approach is fostered through collaborations with physicians and patient advocates to equip clinicians with genetic tools for tailoring treatment plans. SkylineDx has collaborated with Mayo Clinic on the CP-GEP model, which has been clinically validated in multiple studies, and it launched the Guideline-Informed Risk Assessment Initiative in 2026. Revenue is reported in the range of $10 million to $25 million.
1-888-653-2347 
support@leadiq.com 
